The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy

Journal of Urology

Volumn 163, Issue 1, 2000, Pages 174-178

  Sebo, Thomas J ^a   Bock, Brian J ^a   Cheville, John C ^a   Lohse, Christine ^a   Wollan, Peter ^a   Zincke, Horst ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adenocarcinoma; Needle biopsy; Predictive value of tests; Prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CANCER STAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY;

EID: 0033992281     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67998-0     Document Type: Article

References (28)

1. Manyak, M. J. and Javitt, M. C.: The role of computerized tomography, magnetic resonance imaging, bone scan, and monoclonal antibody nuclear scan for prognosis prediction in prostate cancer. Semin Urol Oncol, 16: 145, 1998.
2. Ackerman, D. A., Barry, J. M., Wicklund, R. A. et al: Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol, 150: 1845, 1993.
3. Blackwell, K. L., Bostwick, D. G., Myers, R. P. et al: Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. J Urol, 151: 1565, 1994.
4. Partin, A. W., Kattan, M. W., Subong, E. N. et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA, 277: 1445, 1997.
5. Egawa, S., Suyama, K., Matsumoto, K. et al: Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology, 52: 433, 1998.
6. Epstein, J. I , Chan, D. W., Sokoll, L. J. et al: Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol, 160: 2407, 1998.
7. Polascik, T. J., Pearson, J. D. and Partin, A. W.: Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen. Semin Urol Oncol, 16: 160, 1998.
8. Catalona, W. J., Smith, D. S., Ratliff, T. L. et al: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA, 270: 948, 1993.
9. Farkas, A., Schneider, D., Perrotti, M. et al: National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening. Urology, 52: 444, 1998.
10. Roberts, R. O., Bergstralh, E. J., Katusic, S. K. et al: Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Urol, 161: 529, 1999.
11. Ferreiro, J. A., Myers, J. L. and Bostwick, D. G.: Accuracy of frozen section diagnosis in surgical pathology: review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester. Mayo Clin Proc, 70: 1137, 1995.
12. Hammond, E. H. and Grignon, D. J.: Current status of tissue markers as prognostic factors in prostatic adenocarcinoma. Int J Rad Oncol, 31: 419, 1995.
13. Lee, C. T. and Oesterling, J. E.: Diagnostic markers of prostate cancer: utility of prostate-specific antigen in diagnosis and staging. Sem Surg Oncol, 11: 23, 1995.
14. Schroder, F. H.: Screening, early detection, and treatment of prostate cancer: a European view. Urology, 46: 62, 1995.
15. Walsh, P. C.: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. J Urol, 158: 1618, 1997.
16. Holzman, D.: Algorithms vie for diagnostic role in prostate cancer. J Nat Cancer Inst, 89: 13, 1997.
17. Bostwick, D. G.: Practical clinical application of predictive factors in prostate cancer. A review with an emphasis on quantitative methods in tissue specimens. Anal Quant Cytol Histol, 20: 323, 1998.
18. Wakui, S., Furusato, M., Itoh, T. et al: Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol, 168: 257, 1992.
19. Peters-Gee, J. M., Miles, B. J., Cerny, J. C. et al: Prognostic significance of DNA quantitation in stage D1 prostate carcinoma with the use of image analysis. Cancer, 70: 1159, 1992.
20. Peters-Gee, J. M.: An update on the role of ploidy in prostate carcinoma. Henry Ford Hosp Med J, 40: 99, 1992.
21. Ross, J. S., Figge, H., Bui, H. X. et al: Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer. Cancer, 74: 2811, 1994.
22. Silberman, M. A., Partin, A. W., Veltri, R. W. et al: Tumor angiogenesis correlates with progression after radical prostatectomy but not w-ith pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer, 79: 772, 1997.
23. Cheng, L., Sebo, T. J., Slezak, J. et al: Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer, 83: 2164, 1998.
24. Bostwick, D. G. and Iczkowski, K. A.: Microvessel density in prostate cancer: prognostic and therapeutic utility. Semin Urol Oncol, 16: 118, 1998.
25. Egan, A. J. and Bostwick, D. G.: Prediction of e-xtraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. Am J Surg Pathol, 21: 1496, 1997.
26. Wills, M. L., Sauvageot, J., Partin, A. W. et al: Ability of sextant biopsies to predict radical prostatectomy stage. Urology, 51: 759, 1998.
27. Goto, Y., Ohori, M. and Scardino, P. T.: Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report. Int J Urol, 5: 337, 1998.
28. Ogawa, O., Egawa, S., Arai, Y. et al: Prooperative predictors for organ-confined disease in Japanese patients with stage T1c prostate cancer. Int J Urol, 5: 454, 1998